Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats, Antimicrobial Agents and Chemotherapy, August 2017, ASM Journals,
DOI: 10.1128/aac.00959-17.
You can read the full text:
Contributors
The following have contributed to this page
